Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Non Operating Income: 2021-2023

Historic Non Operating Income for Cullinan Therapeutics (CGEM) over the last 2 years, with Dec 2023 value amounting to -$117,000.

  • Cullinan Therapeutics' Non Operating Income fell 139.26% to -$117,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $239,000, marking a year-over-year increase of 305.08%. This contributed to the annual value of -$199,000 for FY2024, which is 183.26% down from last year.
  • As of Q4 2023, Cullinan Therapeutics' Non Operating Income stood at -$117,000, which was down 165.00% from $180,000 recorded in Q3 2023.
  • Cullinan Therapeutics' Non Operating Income's 5-year high stood at $298,000 during Q4 2022, with a 5-year trough of -$241,000 in Q2 2022.
  • Its 3-year average for Non Operating Income is $28,800, with a median of $1,000 in 2021.
  • Over the last 5 years, Cullinan Therapeutics' Non Operating Income had its largest YoY gain of 7,350.00% in 2022, and its largest YoY loss of 2,912.50% in 2022.
  • Over the past 3 years, Cullinan Therapeutics' Non Operating Income (Quarterly) stood at $4,000 in 2021, then soared by 7,350.00% to $298,000 in 2022, then tumbled by 139.26% to -$117,000 in 2023.
  • Its last three reported values are -$117,000 in Q4 2023, $180,000 for Q3 2023, and $69,000 during Q2 2023.